产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 Tofacitinib Cit...

Tofacitinib Citrate

540737-29-9
企业标准
药用级

产品详情

Tofacitinib Citrate
其他西药原料
540737-29-9
企业标准
药用级
Tofacitinib Citrate,枸橼酸托法替尼
中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

产品描述:外观:白色至类白色粉末最大单杂:≤0.1%总杂:≤0.5%含量:98.0%~102.0%
补充信息:
Tofacitinib Citrate(枸橼酸托法替布)是一种JAK抑制剂,分子式为C16H20N6O·C6H8O7,CAS号为540737-29-9。它主要用于治疗中重度类风湿性关节炎(RA)、银屑病关节炎(PsA)和溃疡性结肠炎(UC)。通过抑制JAK通路,Tofacitinib Citrate可调节免疫反应,减轻炎症和症状。该药物适用于对传统DMARDs(改善病情抗风湿药)反应不佳的患者,常见剂型为口服片剂。使用时需遵医嘱,注意可能的副作用,如感染风险增加。
浙江瑞联医药有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

ZHEJIANG RUILIAN PHARMACEUTICAL CO..LTD., who engaged in Pharmaceutical field since 2010, we provide outsourcing services,high quality,technical support at affordable cost; intellectual property(lP) are carefully considered as well. We have professionaland extensive networks in Europe, India and Africa. Fast response, Reasonable cost and In-time delivery are TOP3 guidline for our customers.We pay much attention to EHS as well, long term and safty supply is our care to customers.We sincerely look forward to being your reliable partner, offering you high-quality & Affordable products.
业务类型:
成立日期:
年营业额:
主营产品类别: